MedPath

Phase l/ll study of adjuvant chemotherapy (TC therapy) after concurrent chemoradiation in cervical cancer with lymphadenopathy

Phase 1
Conditions
Cervical cancer with lymphadenopathy
Registration Number
JPRN-UMIN000004897
Lead Sponsor
The University of Tokushima Graduate School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

severe complications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PFS, tixicity
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath